We recently compiled a list of the Top 10 Oncology Stocks to Buy Now. Nuvation Bio Inc. stands seventh on our list among the best oncology stocks. TheFly reported on January 12 that H.C. Wainwright reduced its price target on NUVB to $17 from$18 while maintaining a Buy rating. The firm said the company’s fourth-quarter Ibtrozi sales came in line with expectations. On the same day, NUVB reported preliminary Q4 2025 net product revenue of approximately $15.7 million for IBTROZI (taletrectinib). The compan ...